Health Sciences Library Virtual Displays

This brand new text has been written by internationally renowned authors at the front lines of pulmonary medicine research. COPD is a problem of increasing global importance, and this reference successfully brings together all the latest developments in the field in a single volume. It focuses particularly on the pathobiology of COPD and treatment options available.

The only international clinical textbook for COPD - one of the top 5 causes of death and disability worldwide The only COPD textbook to include the latest national and international guidelines and the newer therapeutic agents in COPD treatment International team of contributors covers all aspects of COPD - from physiology and epidemiology to diagnosis and treatment Everything the busy physician needs to understand, diagnose and treat the COPD patient: Structure and physiology of the respiratory system Clinical considerations and allied conditions Therapy (including current and developing treatments) Diagnostic tests used in daily practice

Chronic obstructive pulmonary disease (COPD) is an increasingly important health problem world-wide. Whereas most other leading diseases have shown a decline in the past decades, COPD morbidity and mortality is on a steady increase. Exacerbations are usually defined as an increase in cough, a change in the colour or quantity of sputum, and a worsening dyspnea. The role of bacterial infections and the efficacy of antimicrobial therapy in acute exacerbations of chronic bronchitis (AECD) is still controversial. Exacerbations of chronic bronchitis are a common occurrence in clinical practice and are a leading cause of antibiotic prescription among respiratory infections. It is still uncertain whether each new exacerbation may deteriorate the natural history of chronic bronchitis. Undoubtedly, every episode includes a temporary worsening in lung function and may therefore pose the threat of respiratory failure or death in more severely obstructed patients.

Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory diseases of the developed world and interest in the condition is burgeoning both among physicians encountering the disorder and within the pharmaceutical industry. International guidelines for diagnosis and management have been formulated and our basic understanding of the underlying disease processes has led to major improvements in patient care and the development of new methods of treatment. The new edition of this book reflects these many changes. Developments in the understanding of the underlying disease process, improvements in patient care and new methods of treatment are all covered by an international team of editors and contributors.

This clinical reference for practitioners offers a new and comprehensive look at chronic obstructive lung disease. Global in scale and importance, it is an important cause of morbidity and mortality. Bringing together a roster of internationally renowned contributors from the front lines of pulmonary medicine and research, this book is aimed at practitioners in pulmonary medicine, pathology, thoracic radiology and epidemiology. Its focus is on the pathobiology of chronic obstructive pathology disease and emphysema and its exacerbation of chronic obstructive pulmonary disease and on treatment options.

This thoroughly updated, newly organized edition addresses the need for team care of patients with chronic obstructive pulmonary disease and demonstrates how to organize and manage an effective pulmonary rehabilitation program. A guide for each member of the in-patient and home care pulmonary rehabilitation team, this book combines theory with resources for practice.Chapters cover the following topics: up-to-date coverage of patient assessment; smoking cessation; pharmacologic therapy; nutrition support; aerosol/oxygen therapies; guidelines for marketing/administering a rehabilitation program in the United States and abroad; and forms, protocols and schedules.

In England and Wales, Chronic Obstructive Pulmonary Disease affects 1 in 10 people over the age of 65, which makes it one of the most common and important respiratory disorders in primary care. To date there are 600 000 people diagnosed with COPD (principally chronic bronchitis or emphysema) OCo and the true figure is much higher."

This book, written for pulmonary and family doctors, general practitioners, allergologists, and neuropsychologists, presents cutting-edge clinical research and therapy-oriented knowledge in the field of respiratory medicine. Clinical knowledge is undergoing dramatic improvement. Respiration is one such prominent field. A better understanding of the pathogenesis of respiratory ailments and the regulation of lung ventilation is essential for advances in pharmacotherapy and the patient's quality of life.

This pocketbook is a concise companion for all health care professionals who come into contact with patients with COPD. It covers the full spectrum of COPD management ranging from smoking cessation to advanced COPD, bridging both the primary and secondary care aspects of treatment and discussing the latest advances in our understanding of the pathophysiology and new drug treatments of this disease.